Peptide Cjc1295 Dac for Female Hormone Balance 2mg/Vial 863288-34-0

Peptide CJC1295 DAC for Female Hormone Balance 2mg/Vial 863288-34-0CJC-1295Basic info:Product Name:CJC-1295 DACUnit size:2 mg/vialCAS NO.:863288-34-0Synonyms:CJC-1295 DAC, CJC 1295 with DACSequence:Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Maleimidopropionyl)-NH2Purity:98.69% (HPLC)Physical State:Lyophilized PowderSolubility:Soluble in water or 1% acetic acidStorage:Lyophilized peptides although stable at room temperature for 3 months, should be stored desiccated below -18°C. Upon reconstitution of the peptide it should be stored at 4°C between 2-21 days and for future use below -18°C.TermsProduct is prepared for LABORATORY RESEARCH USE ONLY. The product may not be used for other purposes.
CJC-1295 with DAC Spec.
Product Description: CJC-1295 2mg/Vial
Type: Immune Function AgentsGrade
Standard: Medicine Grade
Classification: Brassinosteroid
CAS: 863288-34-0
MF: C165H271N47O46
Molecular Weight: 3649.30
Purity (HPLC): 98.0%
Appearance: White powder
Single Impurity(HPLC): 1.0%
Amino Acid Composition: 10% of theoretical
Peptide Content(N%): 80%(by %N)
Water Content(Karl Fischer): 6.0%
Acetate Content(HPIC): 15.0%
Mass Balance: 95.0~105.0%COA:
Test
Specification
Result
1
Appearance
White powder
White powder
2
Identity by MS
3367.92+2
3368.0
3
Solubility
Soluble in water or 1% acetic acid at a concentration of ≥1mg/ml to give a clear,colorless solution
Conforms
4
Peptide purity(by HPLC)
≥98.0%
98.90%
5
Relate substance(by HPLC)
Total impurities(%)≤2.0%
Largest single impurity(%)≤1.0%
1.10%
0.57%
6
Acetate content ( HPLC)
≤15.0%
13.09%
7
Whater contant(karl fischer)
≤6.0%
1.48%
8
Bacterial endotoxins
≤5eu/mg
Conforms
9
Assay(by anhydrous acetic acid-free)
95.0-105.0%
98.5%
Description:
CJC-1295 DAC (Drug Affinity Complex), also known as CJC-1295, is a synthetic GHRH (Growth Hormone Releasing Hormone) that is long acting. After administration, it covalently binds to albumin naturally created by the human body, causing it to extend its duration of action. This means it has a far longer half life (between six and eight days) than other peptides like Sermorelin and Mod GRF 1-29 . Sermorelin and Modified GRF 1-29 have a half life of 5-10 minutes , and about 30 minutes , respectively. A shorter half life results in inefficiency because the peptide does not reach the pituitary within enough time for the peptide to become effectual. Unlike Mod GRF 1-29, CJC-1295 DAC is a drug affinity complex, where there is a lysine connection to maleimidoproprionic acid (MPA) .
In the average and healthy human body, growth hormones are kept in the pituitary gland. A GHRH, naturally occurring or synthetic, signals to the pituitary to release growth hormone. Most individuals, naturally, are able to create growth hormone in their pituitary gland. However, some can not release the necessary amount of growth hormone. GHRP increases the amount of growth hormone releasing cells. The quantity released by each cell is unaffected. CJC-1295 DAC, and other peptides like GHRP-6 and GHRP-2, have the possibility of assisting in the attainment of necessary growth hormone levels.
Clinical studies have shown that the administration of CJC-1295, which was developed by ConjuChem, in certain specific situations and intervals, may cause the achievement of normal body weight when GHRH levels are low, greater body weight, and an increase in total pituitary RNA and growth hormone. The last of which suggests that more growth hormone releasing cells were created . Other studies have provided evidence that one administration of CJC-1295 produced sustained elevations of serum growth hormone and insulin-like growth factor 1 levels in normal subjects for nearly fourteen days .
Related products lists:Product NameCAS No.SpecificationAOD-9604CAS 221231-10-32mg/vialCJC-1295DAC2mg/vialCJC-1295CAS 863288-34-02mg/vialDeslorelinCAS 57773-65-620mg/vialDSIPCAS 62568-57-42mg/vialEpitalonCAS 307297-39-810mg/vialFollistatin 3441mg/vialGDF-81mg/vialGHRP-2CAS 158861-67-75mg/vial10mg/vialGHRP-6CAS 87616-84-05mg/vial10mg/vialGonadorelinCAS 34973-08-52mg/vialHexarelinCAS 140703-51-12mg/vial176-1912mg/vial5mg/vialIpamorelinCAS 170851-70-42mg/vial5mg/vialMelanotan ICAS 75921-69-610mg/vialMelanotan IICAS 121062-08-610mg/vialMGF2mg/vial5mg/vialOxytocinCAS 50-56-62mg/vialPEG-MGF2mg/vialPentadecapeptide BPC 1572mg/vialPT141CAS 189691-06-310mg/vialSelank5mg/vialSermorelinCAS 86168-78-72mg/vialTB500CAS 75591-33-42mg/vial5mg/vialTesamorelinCAS 218949-48-52mg/vialTriptorelin AcetateCAS 57773-63-42mg/vial